Phase 3 Study to Evaluate the Efficacy and Safety of Peginterferon Lambda for 48 Weeks in Patients With Chronic HDV
Clinical trial NCT05070364 · UNKNOWN
Trial details
- NCT number
- NCT05070364
- Sponsor
- Eiger BioPharmaceuticals
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-21
- Primary completion
- 2024-06-15
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.